Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03134118
Title Nivolumab in Patients With Type B3 Thymoma and Thymic Carcinoma (NIVOTHYM) (NIVOTHYM)
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors European Organisation for Research and Treatment of Cancer - EORTC
Indications

thymic carcinoma

thymoma

Therapies

Nivolumab

Age Groups: adult | senior
Covered Countries FRA | ESP | BEL


No variant requirements are available.